• Home
  • Services
  • Team
  • Payment
  • Contact Us
  • Home
  • Services
  • Team
  • Payment
  • Contact Us
On November 16, 2009

Will Plavix Competitor Cangrelor Be a Prince Rather than a Frog for The Medicines Co.?

The Medicines Co., which six months ago stopped two likely-to-fail Phase III trials of antiplatelet drug cangrelor, is out to prove its frog of a drug may be a prince after all.


  • By admin  0 Comments 
  • 0 Comments

    © 2023 Business Architects, Inc. All rights reserved. info@bizarchitects.com. Designed by Abel Creative Group.